Vernalis receives $2m milestone as part of research collaboration

Maryam Cockar Sharecast | 21 Apr, 2017 10:11 | | |

pharmaceuticals, drugs, lab
  • 12.38
  • 2.06%0.25
  • Max: 12.75
  • Min: 12.00
  • Volume: 249,623
  • MM 200 : n/a
17:19 16/10/17
  • 13,505.15
  • 0.64%85.22
  • Max: 13,557.19
  • Min: 13,419.93
  • Volume: 0
  • MM 200 : n/a
17:19 16/10/17
  • 1,029.95
  • -0.13%-1.31
  • Max: 1,033.55
  • Min: 1,028.90
  • Volume: 0
  • MM 200 : n/a
17:20 16/10/17
  • 5,244.82
  • -0.37%-19.70
  • Max: 5,275.99
  • Min: 5,239.13
  • Volume: 0
  • MM 200 : n/a
17:20 16/10/17

Shares in Vernalis tumbled on Friday despite the drug developer announcing it had received a $2m milestone under one of its existing research collaborations.

The collaboration was to discover novel small molecules against an undisclosed target using Vernalis' fragment and structure-based drug discovery platform.

Chief executive Ian Garland said: "We are delighted to receive this payment which recognises the success of our research group's work."

Shares in Vernalis were down 13.71% to 21.25p at 0915 BST.

More news

16 Oct US close: Stocks finish higher on impressive factory data

Stocks started the week higher on Monday, on the back of a stronger-than-expected reading on the Empire State factory index and amid somewhat hawkish Fedpseak.

16 Oct Europe close: Political standoff weighs on Spanish stocks

Stocks on the Continent were little changed at the start of the week, save in Spain where the ongoing political standoff between the central government in Madrid and regional officials in Catalonia weighed on sentiment.

16 Oct Mercedes-Benz to recall almost 400,000 vehicles over faulty airbags

German multinational automotive group Daimler, the parent company of Mercedes-Benz, announced on Monday that they would recall nearly 400,000 vehicles that were potentially fitted with a faulty airbag.

16 Oct London close: Stocks slip lower despite gains for miners

London stocks slipped on Monday as miners rallied on the back of Chinese inflation data, but Convatec slid after a profit warning.

16 Oct Airbus chief willing to step down if 'no longer part of the solution'

Tom Enders, chief executive of French aeronautical giant Airbus, said on Sunday that he would be willing to step down from the role he had held since 2012 in an effort to safely guide the firm through ongoing corruption investigations.

16 Oct US open: Stocks push higher following upbeat factory data

Stocks have started the week higher on the back of a stronger-than-expected reading on the Empire State factory index and amid somewhat hawkish Fedpseak.

16 Oct Telit confirms talks to offload automotive division

AIM-quoted machine-to-machine (M2M) communications provider Telit Communications confirmed it was in "very early stage" talks to sell its automotive division.

16 Oct Tuesday preview: UK inflation could top 3pc; results from Pearson, Merlin, Asos

UK and eurozone inflation will be the big focus of the day, while the new reporting season kicks in with Asos, Bellway, London Stocks Exchange, Merlin Entertainment, Pearson and Virgin Money.

16 Oct Stellar Diamonds agrees sale price for Guinea assets

West Africa-focussed diamond development company Stellar Diamonds announced on Monday that it has signed conditional share purchase agreements with Gold Knight - a wholly-owned subsidiary company of BDG Capital - in relation to the proposed sale of Stellar's assets in the Republic of Guinea, as it had previously announced on 5 June and 14 August.

16 Oct Genedrive signs distribution agreement with Sysmex

Near-patient molecular diagnostics company Genedrive announced on Monday that it has signed a distribution agreement with Sysmex Europe, a subsidiary of Sysmex Corporation, for the Genedrive HCV ID Kit and Genedrive platform in the Europe-Middle East-Africa region, with an initial focus on Africa.